期刊文献+

术前外周血血小板与淋巴细胞计数比在预测甲状腺髓样癌患者淋巴结转移中的价值 被引量:3

Value of preoperative platelet-to-lymphocyte ratio in predicting lymph node metastasis for patients with medullary thyroid carcinoma
下载PDF
导出
摘要 目的分析术前外周血血小板与淋巴细胞计数比(platelet-to-lymphocyte ratio,PLR)在预测甲状腺髓样癌患者淋巴结转移中的价值。方法回顾性分析2001年1月-2017年6月在本院初次确诊的63例甲状腺髓样癌患者的临床病历资料,通过ROC曲线分析寻找PLR预测淋巴结转移的最佳Cut-off值,再通过单因素及多因素Logistic回归分析得出甲状腺髓样癌淋巴结转移的危险因素。结果根据ROC曲线分析得出预测甲状腺髓样癌淋巴结转移的PLR最佳cut-off值是107.955。多因素Logistic回归分析显示,肿瘤甲状腺外侵犯(OR:4.255,95%CI:1.158~15.640)、PLR≥107.955(OR:8.384,95%CI:1.934~36.353)均是淋巴结转移的独立预测因素。结论甲状腺髓样癌患者术前外周血PLR值可辅助预测淋巴结转移,高PLR值预示患者淋巴结转移概率较大。 Objective To investigate the predictive value of preoperative platelet-to-lymphocyte ratio (PLR)for lymph node metastasis (LNM)in medullary thyroid carcinoma (MTC)patients.Methods Sixty-three patients diagnosed with MTC in Chinese PLA General Hospital from January 2001 to June 2017 were included in our study.Receiver operating characteristic (ROC)analysis was performed to identify optimal PLR cut-off value,and the related influencing factors of LNM were screened using univariate and multivariate logistic regression analyses.Results The optimal cut-off value of the PLR for predicting LNM obtained from receiver operating characteristic curve analysis was 107.955,with sensitivity of 63.0% and specificity of 94.1%,and the area under the curve was 0.775.Multivariate analysis showed that extrathyroid extension (OR,4.255;95%CI,1.158-15.640) and the PLR ≥107.955 (OR,8.384;95%CI,1.934-36.353)were independent predictive factors of LNM.Conclusion Preoperative PLR is related to LNM in patients with medullary thyroid carcinoma.Furthermore,high value of PLR confers a high risk of LNM.
作者 菅雁兵 徐倪侦 王亚希 田文 JIAN Yanbing;XU Nizhen;WANG Yaxi;TIAN Wen(Department of General Surgery,Chinese PLA General Hospital,Beijing 100853,China)
出处 《解放军医学院学报》 CAS 2018年第11期964-967,共4页 Academic Journal of Chinese PLA Medical School
关键词 甲状腺髓样癌 淋巴结转移 炎症因素 预测因素 medullary thyroid carcinoma lymph node metastasis inflammation prediction
  • 相关文献

参考文献1

二级参考文献14

  • 1Machens A, Dralle H. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside[J]. Mol Cell Endoerinol,2006, 247 ( 1-2 ): 34-40.
  • 2Costante G, Meringolo D, Durante C, et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules [J]. J Clin Endocrinol Metab,2007,92 (2): 450-455.
  • 3Herbert Chen, Rebecca S, Sue O' Dorisio SM, et al. The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer[J]. Pancreas,2010,39(6): 775-783.
  • 4Barber J, Campion L, Kraeber-Bodere F, et al. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma [J].J Clin Endocrinol Metab, 2005,90( 11 ): 6077-6084.
  • 5Roman S, Mehta P,Sosa JA. Medullary thyroid cancer: early detection and novel treatments [J ]. Curr Opin Oncol, 2009,21 (1) : 5-10.
  • 6Howe TC,Padhy AK, Loke K. et al. Role of Tc-99m DMSA (V) scanning and serum calcitonin monitoring in the management of medullary thyroid carcinoma [J]. Singapore Med J, 2008,49(1) : 19-22.
  • 7Kloos RT, Eng C, Evans DB, et al. Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association [J]. Thyroid,2009, 19(6):565-612.
  • 8Greenblatt DY, Elson D, Mack E, et al. Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer [ J ]. Asian J Surg,2007,30 ( 2 ): 108-112.
  • 9Skinner MA, Moley JA, Dilley WG, et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A [ J ]. N Engl J Med, 2005,353(11): 1105-1113.
  • 10Kebebew E, Greenspan FS, Clark OH, et al. Extent of disease and practice patterns for medullary thyroid cancer [J]. J Am Coll Surg,2005,200 (6): 890-896.

共引文献8

同被引文献19

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部